Amryt Pharma plc logo
Amryt Pharma plc AMYT
report update icon

Quarterly report 2021-Q4
added 05-23-2026

Amryt Pharma plc Operating Expenses | AMYT

Annual Operating Expenses Amryt Pharma plc

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- 109 M 52.2 M 27.9 M 25.9 M 6.95 M - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
109 M 6.95 M 44.4 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer Operating Expenses Price % 24h Market Cap Country
Albireo Pharma Albireo Pharma
ALBO
163 M - -0.23 % $ 916 M usaUSA
bluebird bio bluebird bio
BLUE
265 M - - $ 546 M usaUSA
Landos Biopharma Landos Biopharma
LABP
22.7 M - 0.58 % $ 144 M usaUSA
CASI Pharmaceuticals CASI Pharmaceuticals
CASI
61.3 M - - $ 35.4 M usaUSA
ContraFect Corporation ContraFect Corporation
CFRX
64.6 M - -5.16 % $ 5.39 M usaUSA
Sigilon Therapeutics Sigilon Therapeutics
SGTX
56.6 M - - $ 728 M usaUSA
Regulus Therapeutics Regulus Therapeutics
RGLS
50 M - - $ 155 M usaUSA
NGM Biopharmaceuticals NGM Biopharmaceuticals
NGM
156 M - - $ 127 M usaUSA
Aravive Aravive
ARAV
80 M - -13.39 % $ 1.45 M usaUSA
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
61.5 M - - $ 231 M usaUSA
Crinetics Pharmaceuticals Crinetics Pharmaceuticals
CRNX
340 M $ 84.95 0.13 % $ 7.99 B usaUSA
Acer Therapeutics Acer Therapeutics
ACER
24.6 M - 2.71 % $ 14 M usaUSA
Gilead Sciences Gilead Sciences
GILD
13.5 B $ 166.01 -0.31 % $ 207 B usaUSA
Assembly Biosciences Assembly Biosciences
ASMB
84.4 M $ 22.14 -1.6 % $ 248 M usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
137 M - - $ 2.02 B usaUSA
Turning Point Therapeutics Turning Point Therapeutics
TPTX
269 M - -0.13 % $ 3.73 B usaUSA
Orgenesis Orgenesis
ORGS
19.4 M - -33.86 % $ 61.2 M usaUSA
TCR2 Therapeutics TCR2 Therapeutics
TCRR
153 M - - $ 58.1 M usaUSA
ASLAN Pharmaceuticals Limited ASLAN Pharmaceuticals Limited
ASLN
55.7 M - -14.27 % $ 1.7 M singaporeSingapore
Adverum Biotechnologies Adverum Biotechnologies
ADVM
140 M - - $ 86.2 M usaUSA
BELLUS Health BELLUS Health
BLU
77.9 M - - $ 2.47 B canadaCanada
Intra-Cellular Therapies Intra-Cellular Therapies
ITCI
228 M - - $ 13.6 B usaUSA
Marinus Pharmaceuticals Marinus Pharmaceuticals
MRNS
69.7 M - - $ 29.6 M usaUSA
GeoVax Labs GeoVax Labs
GOVX
4.44 M $ 1.83 -4.45 % $ 8.35 M usaUSA
Unity Biotechnology Unity Biotechnology
UBX
31.2 M - -33.41 % $ 3.37 M usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
127 M - - $ 10.1 M usaUSA
Tyme Technologies Tyme Technologies
TYME
25.5 M - 8.07 % $ 54 M usaUSA
Karuna Therapeutics Karuna Therapeutics
KRTX
495 M - - $ 12.2 B usaUSA
Revance Therapeutics Revance Therapeutics
RVNC
317 M - - $ 309 M usaUSA
Aptinyx Aptinyx
APTX
62.6 M - -39.0 % $ 4.57 M usaUSA
TRACON Pharmaceuticals TRACON Pharmaceuticals
TCON
21.3 M - -1.38 % $ 46.8 M usaUSA
Forward Pharma A/S Forward Pharma A/S
FWP
3.87 M - -0.75 % $ 18.7 M danmarkDanmark
9 Meters Biopharma 9 Meters Biopharma
NMTR
42 M - -42.97 % $ 1.05 M usaUSA
Theratechnologies Theratechnologies
THTX
77.7 M - - $ 83.9 M canadaCanada
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
10.1 M - 3.16 % $ 1.9 M usaUSA
Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc
ADAP
247 M - -15.15 % $ 60.3 M britainBritain
TFF Pharmaceuticals TFF Pharmaceuticals
TFFP
22.6 M - -60.05 % $ 125 K usaUSA
Codiak BioSciences Codiak BioSciences
CDAK
92.5 M - -55.98 % $ 2.15 M usaUSA
Sage Therapeutics Sage Therapeutics
SAGE
474 M - - $ 527 M usaUSA
Paratek Pharmaceuticals Paratek Pharmaceuticals
PRTK
114 M - - $ 121 M usaUSA
AVEO Pharmaceuticals AVEO Pharmaceuticals
AVEO
21.8 M - - $ 521 M usaUSA
Cyclerion Therapeutics Cyclerion Therapeutics
CYCN
3.21 M $ 34.99 3.77 % $ 147 M usaUSA
Seelos Therapeutics Seelos Therapeutics
SEEL
42.7 M - -47.76 % $ 6.27 M usaUSA
Завод ДИОД Завод ДИОД
DIOD
249 M - - - russiaRussia
Kiromic BioPharma Kiromic BioPharma
KRBP
23.8 M - 6.61 % $ 3.08 M usaUSA
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
226 M - - $ 2.18 B usaUSA
Fusion Pharmaceuticals Fusion Pharmaceuticals
FUSN
101 M - - $ 1.41 B canadaCanada
Gritstone Oncology Gritstone Oncology
GRTS
156 M - 0.42 % $ 213 M usaUSA
Aridis Pharmaceuticals Aridis Pharmaceuticals
ARDS
23.4 K - 17.91 % $ 11.1 M usaUSA